Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M263Revenue $M658Net Margin (%)-0.3Z-Score4.0
Enterprise Value $M292EPS $-0.3Operating Margin %0.2F-Score6
P/E(ttm))969Cash Flow Per Share $4.4Pre-tax Margin (%)-0.6Higher ROA y-yY
Price/Book1.110-y EBITDA Growth Rate %0Quick Ratio2.6Cash flow > EarningsY
Price/Sales0.45-y EBITDA Growth Rate %0Current Ratio4.4Lower Leverage y-yY
Price/Cash Flow4.1y-y EBITDA Growth Rate %-55.2ROA % (ttm)-0.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-0.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M8.2ROI % (ttm)5.3Gross Margin Increase y-yN

Gurus Latest Trades with REX

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
REXJohn Keeley 2008-06-30 Sold Out -0.01%$11.58 - $18.6
($15.8)
$ 33.92115%Sold Out0
REXJohn Keeley 2007-12-31 Add$15.2 - $18.08
($16.5)
$ 33.92106%Add 32.43%49,000
REXJohn Keeley 2007-06-30 Buy 0.01%$16.16 - $19.89
($17.4)
$ 33.9295%New holding, 36000 sh.36,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

REX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


REX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BRUGGEMAN DOUGLASCFO; VP-Finance; Treasurer 2013-06-10Sell7,000$30.824.77view
TOMCHIN LAWRENCEDirector 2013-06-07Sell3,000$307.63view
BRUGGEMAN DOUGLASCFO; VP-Finance; Treasurer 2013-05-30Sell3,200$30.256.74view
Cope, Gary GordonSenior Officer 2013-05-21Buy11,500$0.398179.49view
Cope, Gary GordonSenior Officer 2013-05-21Buy5,000$0.388397.37view
Cope, Gary GordonSenior Officer 2013-05-21Buy7,000$0.359125.71view
Cope, Gary GordonSenior Officer 2013-05-16Buy1,000$0.368869.44view
Cope, Gary GordonSenior Officer 2013-05-16Buy24,000$0.378627.03view
Cope, Gary GordonSenior Officer 2013-05-16Buy15,000$0.398179.49view
Cope, Gary GordonSenior Officer 2013-05-14Buy12,500$0.47972.5view

Press Releases about REX :

Quarterly/Annual Reports about REX:

News about REX:

Articles On GuruFocus.com
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 

More From Our Partners
Biotech Stock Mailbag: 2013 Clinical Trials Calendar Jun 7 2013 - THESTREET

Add Notes, Comments or Ask Questions

Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK